Development of an efficient stability‐indicating LC–MS/MS method for the analysis of selexipag and characterization of its degradation products-Reference-Cited by-同舟云学术

Development of an efficient stability‐indicating LC–MS/MS method for the analysis of selexipag and characterization of its degradation products

Published:2021-06-02 Issue:10 Volume:35 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Amara Babu Namburi L. A.¹,Koganti Kalyani¹,Palakeeti Babji²,Srinivas Koduri S. V.³,Rao Koya Prabhakara¹^ORCID

Affiliation:

1. New Generation Materials Lab (NGML), Department of Science and Humanities Vignan's Foundation for Science, Technology and Research (VFSTR) (Deemed to be University), Vadlamudi Guntur Andhra Pradesh India

2. Department of Chemistry National Institute of Technology Warangal Telangana India

3. Syngene International LTD, Bommasandra Bangalore Karnataka India

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.5178

Reference23 articles.

1. Stability indicating assay method development and validation for selexipag in pharmaceutical dosage form;Aashka Joshi M. S.;World Journal of Pharmaceutical Research,2020

2. Bioanalytical LC-MS/MS method for Determination and comparison of Selexipag Assay in various Biological materials and its Application to Pharmacokinetics Studies in Rat plasma

3. Hyperthyroidism and other causes of thyrotoxicosis: Management guideline of the American thyroid association and American association of clinical endoclinologists;Bahn C. R. S.;Thyroid,2010

4. Development and validation of bioanalytical method for the quantitative estimation of Selexipag in biological matrices using LC‐MS/MS;Bhadru B.;Journal of Pharmaceutical Sciences and Research,2019

5. Mechanisms and modifiers of reflex induced cutaneous vasodilation and vasoconstriction in humans

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A liquid chromatography–tandem mass spectrometry method development for the quantification of favipiravir drug and its related impurities in rat plasma and its application to pharmacokinetic studies;Biomedical Chromatography;2023-12-21

2. Stability indicating LC-MS/MS method and validation of Selexipag impurities and identification of its force degradation products;Results in Chemistry;2023-12

3. A new HPLC method for selexipag analysis in pharmaceutical formulation and bulk form;European Journal of Life Sciences;2023-08-28

4. Spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical review;Bulletin of the National Research Centre;2023-02-20

5. Assessment of environmental impact of a novel stability-indicating RP-HPLC method and reported methods for the determination of selexipag in bulk and dosage form: A comparative study using different greenness assessment tools;Microchemical Journal;2023-02